Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.
What Is the Forecast for the Contraceptive Drugs And Devices Market from 2024 to 2025?
The market for contraceptive drugs and devices has seen significant growth recently. The market value, which is expected to increase from $25.30 billion in 2024 to $27.24 billion in 2025, represents a compound annual growth rate (CAGR) of 7.7%. The substantial growth during the historic period can be associated with factors such as population expansion, increased recognition of family planning, government support and funding, a rising workforce of women, and progress in contraceptive innovations.
What Is the Projected Market Size of the Contraceptive Drugs And Devices Market?
In the coming years, the market for contraceptive drugs and devices is anticipated to witness robust growth. The market is estimated to expand to $36.31 billion by 2029, with a compound annual growth rate (CAGR) of 7.5%. This projected growth can be ascribed to a rising demand for long-acting reversible contraceptives, a heightened focus on women’s reproductive health, an increased incidence of sexually transmitted infections, and growing accessibility via e-commerce and telehealth. Other contributing factors include favorable healthcare policies and insurance coverage. The market forecast also indicates prominent trends such as smart contraceptive devices equipped with digital tracking, biodegradable implants and patches, hormone-free contraceptive innovations, fertility monitoring apps driven by AI, and 3D printed custom-fit contraceptive devices.
Download The Free Sample Report Here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24197&type=smp
Who are the Major Competitors in the Contraceptive Drugs And Devices Market Outlook?
Major companies operating in the contraceptive drugs and devices market are Pfizer Inc., Johnson & Johnson Services Inc., Merck & Co Inc., Bayer AG, Viatris Inc., Teva Pharmaceuticals Ltd, Lupin Limited, CooperSurgical Inc., Mithra Pharmaceuticals, DKT International, Fuji Latex Co Ltd, Agile Therapeutics Inc., Cupid Limited, Veru Inc., Eskag Pharma Pvt. Ltd., Biosante Pharmaceuticals Inc., HLL Lifecare Limited, Afaxys Inc., The Female Health Company (FC2), Mayer Laboratories Inc., Daré Bioscience Inc.
What Is Fueling Growth in the Contraceptive Drugs And Devices Market?
The contraceptive drugs and devices market is projected to grow due to increasing government initiatives focused on reproductive health. Government strategies widely focus on improving reproductive health by promoting public awareness, channeling funding, and improving accessibility to services. The surge in government initiatives related to reproductive health is attributed to the growing realization of the value of addressing factors such as maternal health, family planning, and accessibility to required health care services. These factors are integral to societal health and progress. The primary objective of government initiatives for contraceptive drugs and devices is to enhance access to cost-effective and efficient family planning methodologies. This ensures that individuals have the freedom to make informed decisions concerning their reproductive health. For example, according to information released by the Australian Government Department of Foreign Affairs and Trade in November 2024, an allocation of $56.8 million will be made by Australia as part of a new initiative designed to endorse sexual and reproductive health and rights in Southeast Asia. Consequently, the contraceptive drugs and devices market expansion is being propelled by the increasing number of government initiatives centered around reproductive health.
Request For A Customized Report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=24197&type=smp
Which Contraceptive Drugs And Devices Market Segments Are Growing the Fastest?
The contraceptive drugs and devices market covered in this report is segmented –
1) By Product: Contraceptive Drugs, Contraceptive Devices
2) By Technology: Traditional Methods, Digital Contraceptive Apps, Wearable Devices, Long-Acting Reversible Contraceptives (LARCs)
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Clinics, Online Channels, Public Channels And Non-Governmental Organizations, Other Distribution Channels
4) By End User: Male, Female
Subsegments:
1) By Contraceptive Drugs: Oral Contraceptive Pills, Injectable Contraceptives, Contraceptive Patches, Vaginal Rings, Emergency Contraceptive Pills, Hormonal Implants
2) By Contraceptive Devices: Male Condoms, Female Condoms, Intrauterine Devices (IUDs), Diaphragms And Cervical Caps, Contraceptive Sponges, Sterilization Devices
Which Industry Trends Are Shaping the Future of the Contraceptive Drugs And Devices Market?
Leading firms in the contraceptive drugs and devices market are creating novel products such as the contraceptive vaginal rings to enhance user-friendliness and increase the range of long-acting contraceptive alternatives. The contraceptive vaginal ring is a flexible device that releases hormones when placed in the vagina to inhibit ovulation, thereby preventing pregnancy. Xiromed LLC, an American pharmaceutical company, launched an innovative product called EnilloRing in October 2023. This soft and flexible vaginal ring is designed to release a blend of etonogestrel (a progestin) and ethinyl estradiol (an estrogen) continuously over a three week period to prevent ovulation. As a generic version with bioequivalence to NuvaRing, it provides an affordably priced monthly birth control option which not only removes the requirement for daily dosing but also upholds the same safety, efficiency, and tolerance levels as the original version.
Access The Full Report Here:
Which Countries Are Leading the Contraceptive Drugs And Devices Market?
North America was the largest region in the contraceptive drugs and devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the contraceptive drugs and devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Purchase The Full Report Today:
https://www.thebusinessresearchcompany.com/customise?id=24197&type=smp
This Report Delivers Insight On:
1. How big is the contraceptive drugs and devices market, and how is it changing globally?
2. Who are the major companies in the contraceptive drugs and devices market, and how are they performing?
3. What are the key opportunities and risks in the contraceptive drugs and devices market right now?
4. Which products or customer segments are growing the most in the contraceptive drugs and devices market?
5. What factors are helping or slowing down the growth of the contraceptive drugs and devices market?
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Get in touch with us:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 310-496-7795
Europe +44 7882 955267
Asia & Others +44 7882 955267 & +91 8897263534
Email us at info@tbrc.info
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model